EASTGATE BIOTECH ANNOUNCES LICENSING/DISTRIBUTION MOU WITH BUPHARCO FOR THE INSULIN MOUTH RINSE IN THE PHILIPPINES FOR TYPE 2 DIABETES PATIENTS
WEST CALDWELL, NJ and TORONTO, March 5, 2018 (AccessNewswire-) EastGate Biotech Corp. (PinkSheets: ETBI), a pharmaceutical company ...